Trump’s Prospects Starting to Stir as Clinton’s Health Remains a Question

Hillary Clinton’s personal health scare is a new market risk for jittery investors already spooked by central banks poised to disappear into the woodwork in the face of lax money policies. The 68-year-old Democratic… Read more »

Google Parent, Sanofi to Invest $500 Million in Diabetes Joint Venture

French drugmaker Sanofi SA (Paris) and Verily, the life sciences unit of Google parent Alphabet Inc. (Mountain View CA) on Monday said they would invest about $500 million in a… Read more »

CDC Director Warns Zika to Be Sobering, Endemic US Problem; Congress Finally Showing Signs of Action.

A likely surge this fall in the number of US infants born with grave defects will serve as a sobering admonition to members of Congress who’ve stalemated over funds to… Read more »

Regular Exercise Saves $2,500/Yr for People with Heart Disease; That’s Real Money for Most of Us.

Getting recommended levels of exercise weekly may help keep down annual medical costs both for people with and without cardiovascular disease, according to new research in Journal of the American Heart Association. Patients… Read more »

Medicare’s Forgotten History Shows How to Rescue Obamacare.

In the last few years, even though premiums in the Affordable Care Act’s health insurance marketplaces were rising, most customers could avoid a big price rise by shopping for a… Read more »

U.S. Study Raises New Concern for Zika Spread; Congress Back, but Just 19 Days Left to Solve Zika Funding Impasse.

According to a Reuters report, a new study has found genetic fragments of Zika in the eyes and the tears of laboratory mice infected with the virus–a finding that offers… Read more »

Good News for Mylan after Hellish Week: Another Win in Patent War Over MS Drug; Lawyers on Both Sides Rejoice.

Teva Pharmaceutical Industries Ltd. (Petach Tikva ISR) had a third patent on its top-selling multiple sclerosis drug, Copaxone, invalidated last Thursday by a U.S. agency, a further blow to its… Read more »

Carmat Jumps after First Implantation of Bioprosthetic Artificial Heart; Says Device May Last “For Years.”

Carmat SA (Villacoublay FRA) announced that its artificial heart has been implanted for the first time in an important clinical study that may lead to European regulatory approval. It is similarly… Read more »

Theranos Pulls Zika Test from FDA Review after Problems Flagged; Anyone Else Hear a Death Knell?

Blood-testing firm Theranos Inc. (Palo Alto CA) said it voluntarily withdrew a request to the U.S. Food and Drug Administration for emergency clearance of its new Zika-virus blood test. Theranos… Read more »

Study Suggests Revolutionary Drug Could Benefit Patients with Early Stage Alzheimer’s

A trial of a new Alzheimer’s drug has shown it could benefit patients in the earliest stages of the disease, raising hopes that a treatment for the devastating condition may… Read more »